News About: Pharm. Industry
Top 25% of Pharmacies Monopolize Prescription Dispensing
Last year, only 5,000 out of 20,000 pharmacies got paid more than the average of the insurance reimbursement, and the pharmacies that got the most insurance reimbursement had 81 times more than the average of the reim...
No Blockbuster in the Obesity Drug Market, but Fluctuation in Next Year?
The obesity drug market which was reorganized with a psychotropic appetite suppressant has not produced blockbuster for a long time.
It is understood because of strong regulatory policies regarding psychotropic appet...
Reflux Esophagitis Market, Domestic Brand ‘Fights Hard’
Domestic brands in the market of reflux esophagitis treatments fight well. Especially, among the PPI (Proton Pump Inhibitor) products, Nexium remains strong. However, the domestic pharmaceutical companies are sharpeni...
Post ‘Warfarin’ Competition, Who Will Win? ‘Xarelto’ may be? IMS Data Analysis since Last Year
Three major brands are having a mixed feeling of joy and sadness on the post ‘Warfarin’ competition which is happening 60 years after the launch of the‘Warfarin’.
New oral Anticoagulants called‘Xarelto’ (Bayer), ‘Pra...
After Selection as a NIP, Sales of Prevenar 13 and Synflorix Had a Significant Increase
After Pneumococcal vaccine was selected as a NIP (National Immunization Program) this May, Prevenar 13 of Pfizer and Synflorix of GSK have increased their sales as expected. However, Synflorix has attracted more atten...
BMS Korea’s ‘Baraclude tablet 0.5 mg’ is the most commonly prescribed drug in past three year
According to the list of prescription drugs with higher sales in last three years, it was identified that BMS Korea’s ‘Baraclude tablet 0.5 mg’ is the most commonly prescribed drug in past three year.
'Baraclude tabl...
Health Insurance Review & Assessment released list of medicines for generic substitution in September whose number was 7525 items
Health Insurance Review & Assessment released list of medicines for generic substitution in September and the number of drugs was 7525 items which is steadily increasing from 7209 items in April, 7337 items in June, 7...
Sales of TNF-a inhibitor for rheumatoid arthritis increased by 21% compared to the previous year
On September 4, according to the sales analysis of recently released TNF-a inhibitor and new drug for rheumatoid arthritis treatment in the second half of the year, its sales increased by 21% compared to the previous ...
Stock prices of major new drug developing companies increased by 32.8% this year
On September 4, according to the report of Shinhan Investment & Securities, stock prices of major new drug developing companies increased by 32.8% this year.
In case of Genexine whose largest shareholder changed to H...
Pharmaceutical companies are operating dozens of CSOs to maximum 100 companies
CSO recently has become issues, and pharmaceutical industry identifies that so-called big 3 pharmaceutical companies are operating dozens of CSOs to maximum 100 companies.
Also, it was known that some pharmaceutical ...
